1. H.R.6–115th Congress (2017–2018). (2018, October 24). SUPPORT for patients and communities act https://www.congress.gov/bill/115th-congress/house-bill/6.
2. American College of Obstetricians and Gynecologists. (2017). Opioid use disorder in pregnancy. ACOG Committee Opinion No, 711, 1–14. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/08/opioid-use-and-opioid-use-disorder-in-pregnancy.
3. Board, A., D’Angelo, D., von Essen, S., Denny, B., Miele, C., Dunkley, K., Baillieu, D., & Kim, R. (2023). S. Polysubstance use during pregnancy: The importance of screening, patient education, and integrating a harm reduction perspective. Drug and Alcohol Dependence, Volume 247, 2023, 109872, ISSN 0376–8716, https://doi.org/10.1016/j.drugalcdep.2023.109872.
4. Branham, D. K., Peters, C., & Sommers, B. D. (2021). Estimates of uninsured adults newly eligible for Medicaid if remaining non-expansion states expand. U.S. Department of Health and Human Services:text=Estimates%20of%20Uninsured%20Adults%20Newly%20Eligible%20for%20Medicaid,to%20138%25%20of%20the%20Federal%20Poverty%20Level%20%28FPL%29. https://aspe.hhs.gov/sites/default/files/private/pdf/265621/aspe-data-point-medicaid-expansion-new-eligible.pdf#:~.
5. Bruzelius, E., & Martins, S. S. (2022). US trends in Drug Overdose mortality among pregnant and postpartum persons, 2017–2020. Journal of the American Medical Association, 328(21), 2159–2161. https://doi.org/10.1001/jama.2022.17045.